OTC · LTUS
Lotus Pharmaceuticals, Inc.
Financial Services · Shell Companies
$0.00
Up+$0.00 (+0.00%)
Updated Nov 5, 2026, 8:15 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 164.62K
- P/E ratio
- 143.81
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.01
- Volume
- 500
- Avg. volume
- 33.44K
Price performance · LTUS
LTUS price history
1M range · 6 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
LTUS closed at $0.00 after 6 trading sessions, down 36.73% for the selected period.
- Last close
- $0.00
- Period change
- -36.73%
- Period low
- $0.00
- Period high
- $0.00
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $0.0031 | $0.0031 | $0.0031 | $0.0031 | 500 |
| Nov 2, 2026 | $0.0031 | $0.0031 | $0.0031 | $0.0031 | 1K |
| Oct 28, 2026 | $0.0041 | $0.0041 | $0.0041 | $0.0041 | 10.25K |
| Oct 23, 2026 | $0.0041 | $0.0041 | $0.0036 | $0.0036 | 2.3K |
| Oct 20, 2026 | $0.0049 | $0.0049 | $0.0049 | $0.0049 | 31.85K |
| Oct 15, 2026 | $0.0049 | $0.0049 | $0.0049 | $0.0049 | 20K |
Latest LTUS news
The latest Smart Investors Daily articles mentioning LTUS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LTUS research
Overview
Company profile and research snapshot.
Company profile
LOTUS PHARMS INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
